company background image
A144510 logo

GC Cell KOSDAQ:A144510 Stock Report

Last Price

₩24.65k

Market Cap

₩370.4b

7D

5.1%

1Y

-26.7%

Updated

13 Dec, 2024

Data

Company Financials

GC Cell Corporation

KOSDAQ:A144510 Stock Report

Market Cap: ₩370.4b

A144510 Stock Overview

Develops cell therapy products. More details

A144510 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

GC Cell Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for GC Cell
Historical stock prices
Current Share Price₩24,650.00
52 Week High₩48,800.00
52 Week Low₩21,250.00
Beta0.93
1 Month Change-10.85%
3 Month Change-24.27%
1 Year Change-26.75%
3 Year Change-76.48%
5 Year Change-30.76%
Change since IPO-48.75%

Recent News & Updates

The Market Doesn't Like What It Sees From GC Cell Corporation's (KOSDAQ:144510) Revenues Yet As Shares Tumble 27%

Dec 01
The Market Doesn't Like What It Sees From GC Cell Corporation's (KOSDAQ:144510) Revenues Yet As Shares Tumble 27%

Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price

Oct 14
Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price

Is GC Cell (KOSDAQ:144510) A Risky Investment?

Sep 08
Is GC Cell (KOSDAQ:144510) A Risky Investment?

Recent updates

The Market Doesn't Like What It Sees From GC Cell Corporation's (KOSDAQ:144510) Revenues Yet As Shares Tumble 27%

Dec 01
The Market Doesn't Like What It Sees From GC Cell Corporation's (KOSDAQ:144510) Revenues Yet As Shares Tumble 27%

Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price

Oct 14
Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price

Is GC Cell (KOSDAQ:144510) A Risky Investment?

Sep 08
Is GC Cell (KOSDAQ:144510) A Risky Investment?

We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

Mar 19
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Feb 22
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Jan 18
Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Dec 14
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Shareholder Returns

A144510KR BiotechsKR Market
7D5.1%7.0%3.1%
1Y-26.7%29.7%-5.3%

Return vs Industry: A144510 underperformed the KR Biotechs industry which returned 20.7% over the past year.

Return vs Market: A144510 underperformed the KR Market which returned -5.3% over the past year.

Price Volatility

Is A144510's price volatile compared to industry and market?
A144510 volatility
A144510 Average Weekly Movement7.5%
Biotechs Industry Average Movement8.9%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.6%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A144510 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A144510's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011752James Parkwww.gccell.com

GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC.

GC Cell Corporation Fundamentals Summary

How do GC Cell's earnings and revenue compare to its market cap?
A144510 fundamental statistics
Market cap₩370.42b
Earnings (TTM)-₩3.39b
Revenue (TTM)₩184.36b

2.0x

P/S Ratio

-109.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A144510 income statement (TTM)
Revenue₩184.36b
Cost of Revenue₩137.39b
Gross Profit₩46.96b
Other Expenses₩50.35b
Earnings-₩3.39b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-225.49
Gross Margin25.48%
Net Profit Margin-1.84%
Debt/Equity Ratio11.9%

How did A144510 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

-44%

Payout Ratio